Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report - Quiz - MDSpire

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report

  • By

  • Carlen A. Yuen

  • Mahbod Jafarvand

  • David O. Kamson

  • Eleanor Chu

  • Jennifer E. Soun

  • William H. Yong

  • Frank P. Hsu

  • Hansen Bow

  • Michelle Zheng

  • Shyam M. Srinivas

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report

  • by Carlen A. Yuen, Mahbod Jafarvand, David O. Kamson, Eleanor Chu, Jennifer E. Soun, William H. Yong, Frank P. Hsu, Hansen Bow, Michelle Zheng, Shyam M. Srinivas

  • June 11, 2026

Related Content

Precision Diagnostics and the ADC Revolution

Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics

  • June 10, 2026

  • 15 min
Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer

Editorial: Integrating nutrition in cancer therapy: approaches to improve patient outcomes and survival